GoodRx Holdings Inc(GDRX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 26 at 4:01 PM ET (Korea 10/27 05:01)
Full metrics table
| Index | - | P/E | 75.58 | EPS (ttm) | 0.05 | Insider Own | 74.22% | Shs Outstand | 106.2M | Perf Week | 5.64% |
| Market Cap | 1.21B | Forward P/E | 10.14 | EPS next Y | 15.79% | Insider Trans | -1.08% | Shs Float | 88.0M | Perf Month | 6.27% |
| Enterprise Value | 1.46B | PEG | 1.74 | EPS next Q | 0.08 | Inst Own | 15.7% | Short Float | 4.72% | Perf Quarter | 14.1% |
| Income | 0.02B | P/S | 1.55 | EPS this Y | -13.33% | Inst Trans | 0.25% | Short Ratio | 3.21 | Perf Half Y | 56.14% |
| Sales | 0.79B | P/B | 1.87 | EPS next 5Y | 5.83% | ROA | 0.89% | Short Interest | 4.16M | Perf YTD | 31.37% |
| Book/sh | 1.9 | P/C | 4.1 | EPS past 3/5Y | - | ROE | 2.52% | 52W High | -12.1% ($4.05) | Perf Year | -9.87% |
| Cash/sh | 0.87 | P/FCF | 6.16 | Sales past 3/5Y | 1.3% 7.67% | ROIC | 1.38% | 52W Low | 101.13% ($1.77) | Perf 3Y | -32.06% |
| Dividend Est. | - | EV/EBITDA | 7.97 | EPS Y/Y TTM | -48.77% | Gross Margin | 79.54% | Volatility(W/M) | 3.28% 3.47% | Perf 5Y | -91.97% |
| Dividend TTM | - | EV/Sales | 1.86 | Sales Y/Y TTM | -1.83% | Oper. Margin | 12% | ATR (14) | 0.12 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.38 | EPS Q/Q | -31.94% | Profit Margin | 2.07% | RSI (14) | 57.12 | Recom | 2.73 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.38 | Sales Q/Q | -1.31% | SMA20 | 4.56% ($3.4) | Beta | 1.67 | Target Price | $3.95 |
| Payout | - | Debt/Eq | 0.83 | Earnings | 2026/8/5 | SMA50 | 3.48% ($3.44) | Rel Volume | 0.69 | Prev Close | $3.54 |
| Employees | 697 | LT Debt/Eq | 0.82 | EPS/Sales Surpr. | 0.38% 3.72% | SMA200 | 26.86% ($2.81) | Avg Volume(3M) | 1.30M | Price | $3.56 |
| IPO | 2020/9/23 | Option/Short | Yes/Yes | Trades | 4384 | Volume | 891,942 | Change | 0.56% |
💊 GoodRx Holdings (GDRX) is a U.S.-based healthcare information services company that operates a platform for comparing prescription drug prices and providing discounts. It connects consumers so they can compare prescription prices across pharmacies and obtain discount coupons to lower their medication costs, while expanding its business through marketing solutions for pharmaceutical manufacturers and subscription services.
Over the past 1 year, on the higher side
12% below its 1-year high.
Traded less than usual. That is 69% of its average volume.
GDRX earns at a steady pace
Of every $100 in sales, $12.00 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -13.3% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $797. Peers typically go for $1,452.
Tap to view numbers
Results came in about as expected
Slight tendency to miss estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -92.0%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership is about average
Institutions hold 15.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #13 of 41 in the industry
Based on market cap of $1B.
CERT#12 Certara Inc $2B PER - GDRX#13 GoodRx Holdings Inc $1B PER 75.6 
OMDA#14 Omada Health Inc $1B PER 292.4 
TDOC#15 Teladoc Health Inc $1B PER - 
HSTM#16 Healthstream Inc $1B PER 48.6 
FAQ
What kind of company is GDRX?
GDRX belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of GDRX?
The market cap of GDRX is approximately $1.2B, ranking 2,414 within its sector.
What is the P/E ratio of GDRX?
GDRX has a P/E ratio of approximately 75.6x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for GDRX?
GDRX has recorded a 52-week high of $4.05 and a low of $1.77.
